1. 1Vanda Pharmaceuticals. FDA Approves Vanda Pharmaceuticals’ Fanapt™ for the Treatment of Schizophrenia. Press release, 6 May 2009. http://phx.corporate-ir.net/phoenix.zhtml?c=196233&p=RssLanding&cat=news&id=1285454 (accessed May 2009).
2. 2Vanda Pharmaceuticals. Vanda Pharmaceuticals Announces Receipt of not Approvable Letter from FDA for Iloperidone. Press release, 28 July 2008. http://phx.corporate-ir.net/phoenix.zhtml?c=196233&p=irol-newsArticle&ID=1179851&highlight= (accessed May 2009).
3. 3Vanda Pharmaceuticals. Fanapt (iloperidone) Tablets. http://www.fanapt.com/fanapt-pi-may09.pdf (accessed May 2009).
4. 3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873);Strupczewski;J Med Chem,1995
5. Effects of atypical antipsychotic agents on social behavior in rodents;Corbett;Pharmacol Biochem Behav,1993